B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA (B-NHL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA (B-NHL) trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowThis study is testing an experimental drug called odronextamab against standard therapy for people with aggressive B-cell lymphoma that has returned or stopped responding to their first treatment. The main goal is to see if the new drug is more effective at keeping the cancer fro…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 06:50 UTC
-
New Two-Pronged immune cell therapy tested for tough lymphomas
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of a new type of CAR-T cell therapy. The therapy uses a patient's own modified immune cells to target two proteins (CD19 and CD22) on lymphoma cells. It is for adolescents and adults whose B-cell non-Hodgkin lymphoma has …
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC